Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice

Homeostasis between indigenous intestinal flora and host response may be broken in inflammatory bowel disease. The present study explores whether repeated oral administration of intestinal flora antigens can protect mice against dextran sodium sulphate (DSS)‐induced colitis. Sonicates of Gram‐positive, Gram‐negative, or anaerobic resident bacteria isolated from mouse intestinal flora were fed to BALB/c mice by gastric gavage, with or without cholera toxin. After four weekly doses of 1 mg of these antigen preparations (or of PBS as control), DSS colitis was induced. One week later colitis was evaluated by clinical scores and histology. Mice fed a pool of the three sonicates had decreased inflammation scores (5 (1–14); median (range)) compared with PBS‐fed control animals (15 (7–19); P < 0·05). Decreased inflammation was observed in mice fed anaerobic bacteria antigens (7 (6–11); P < 0·05 versus control), but not in mice fed a pool of Gram‐positive and ‐negative sonicates (16 (12–16)). Inflammation scores of mice fed antigens with cholera toxin were similar to those of PBS‐fed control animals. DSS‐induced colitis can be suppressed by oral administration of normal intestinal flora antigens containing anaerobes.

[1]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[2]  H. Kölbl,et al.  Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models , 1998 .

[3]  P. Rutgeerts,et al.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.

[4]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[5]  N. Lycke The mechanism of cholera toxin adjuvanticity. , 1997, Research in immunology.

[6]  C. Elson,et al.  Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. , 1997, Gastroenterology.

[7]  H. Weiner Oral tolerance: immune mechanisms and treatment of autoimmune diseases. , 1997, Immunology today.

[8]  S. Targan,et al.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. , 1997, The New England journal of medicine.

[9]  J. Mcghee,et al.  Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. , 1996, Journal of immunology.

[10]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[11]  M. Neurath,et al.  Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance , 1996, The Journal of experimental medicine.

[12]  M. Neurath,et al.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin‐10 or antibodies to interleukin‐12 , 1996, European journal of immunology.

[13]  C. Prantera,et al.  An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. , 1996, The American journal of gastroenterology.

[14]  R. Sartor The Role of Endogenous Luminal Bacteria and Bacterial Products in the Pathogenesis of Experimental Enterocolitis and Systemic Inflammation , 1996 .

[15]  A. Bylund-Fellenius,et al.  Dextran sulfate sodium (DSS) induces experimental colitis in CD4(+)-cell depleted, athymic and NK-cell depleted scid mice. , 1996 .

[16]  H. Kiyono,et al.  Essentials of mucosal immunology , 1996 .

[17]  S. Targan,et al.  Clarifying the causes of Crohn's , 1995, Nature Medicine.

[18]  K. Ewe,et al.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.

[19]  P. Howdle,et al.  Peripheral cell‐mediated immune response to mycobacterial antigens in inflammatory bowel disease , 1995, Clinical and experimental immunology.

[20]  K. E. Shroff,et al.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut , 1995, Infection and immunity.

[21]  R. Sartor Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. , 1995, Gastroenterology clinics of North America.

[22]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[23]  A. Blum,et al.  Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. , 1994, Gastroenterology.

[24]  H. Weiner,et al.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.

[25]  Elliot M. Meyerowitz,et al.  The ABCs of floral homeotic genes , 1994, Cell.

[26]  H. Weiner,et al.  Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[28]  W. Strober,et al.  Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice , 1993, Cell.

[29]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[30]  N. Lycke,et al.  Cholera toxin adjuvant greatly promotes antigen priming of T cells , 1993, European journal of immunology.

[31]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[32]  H. Bazin,et al.  Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit , 1992, European journal of immunology.

[33]  H. Weiner,et al.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain , 1992, The Journal of experimental medicine.

[34]  A. Sjölander,et al.  The Adjuvant Action of Cholera Toxin is Associated with an Increased Intestinal Permeability for Luminal Antigens , 1991, Scandinavian journal of immunology.

[35]  A. Pera,et al.  Antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. , 1991, Digestive diseases and sciences.

[36]  T. Ohkusa,et al.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. , 1990, Gastroenterology.

[37]  M. Blaser,et al.  Serum antibodies to mycobacterial antigens in active Crohn's disease. , 1988, Gastroenterology.

[38]  C. Elson,et al.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. , 1984, Journal of immunology.

[39]  E. Lee Split ileostomy in the treatment of Crohn's disease of the colon. , 1975, Annals of the Royal College of Surgeons of England.

[40]  S. Gorbach,et al.  Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. , 1967, Gastroenterology.

[41]  S. Gorbach,et al.  Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. , 1967, Gastroenterology.

[42]  H E M Kay,et al.  Clinical and Experimental Immunology , 1966 .